Identity
a cell-permeable small molecule — a purine nucleoside — that acts as a pharmacological activator of AMPK (AMP-activated protein kinase), the cell's "master metabolic energy sensor." It is itself biologically inert until it enters cells (via adenosine transporters) and is phosphorylated to ZMP, an AMP-mimic that allosterically switches AMPK on. It has been the most widely used AMPK activator in laboratory research for decades — and, separately, a clinical drug candidate (Acadesine).
Mechanism (as proposed)
AICAR is a nucleoside that enters cells through adenosine transporters (ENT1/2, CNT2/3), where it's phosphorylated to ZMP — a molecule that mimics AMP. Rising "AMP-like" signal allosterically activates AMPK, the master sensor that cells use to detect low energy. Activated AMPK flips the metabolic switch from anabolic (storing) to catabolic (burning): it phosphorylates/inactivates ACC (↑fatty-acid oxidation), translocates GLUT4 (↑glucose uptake, insulin-independent), activates PGC-1α (↑mitochondrial biogenesis), and inhibits mTORC1 (↓protein synthesis, ↑autophagy) — collectively reproducing much of the muscle's response to endurance exercise. Elegant and foundational — but note the 2021 caveat that some AICAR actions bypass AMPK entirely.